Blue Whale Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Blue Whale Capital's RGEN Position: Q2 2026 in Review
Blue Whale Capital reduced its Repligen (RGEN) stake by 56% in Q2 2026, selling an estimated $27.7M and leaving 178,377 shares worth $24.3M. The position accounts for 0.77% of the portfolio, ranked #23.
Blue Whale Capital first reported a position in RGEN in Q2 2025 and has held it in 5 quarters since. The position peaked at $50.5M in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Blue Whale Capital held 178,377 shares of Repligen worth $24.3M as of Q2 2026.
- Blue Whale Capital sold 225,823 Repligen shares in Q2 2026, an estimated $27.7M.
- Repligen made up 0.77% of Blue Whale Capital's portfolio in Q2 2026, its #23 holding.
- Blue Whale Capital first reported a position in Repligen in Q2 2025 and has held it in 5 quarters since.
- Blue Whale Capital's Repligen position peaked at $50.5M in Q4 2025.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Blue Whale Capital's 13F filing for Q2 2026, filed 13 Aug 2026.